Azra AI
About Azra AI
Azra AI is a healthcare enterprise platform that utilizes advanced agentic AI, multimodal data integration, and workflow automation to transform fragmented clinical data into actionable intelligence. The company’s solutions are designed to optimize and orchestrate care and clinical trial pathways, ensuring patients receive immediate, coordinated care within health systems. This approach aims to increase patient retention and improve outcomes, with the financial impact made visible through real-time reporting.
For physicians, Azra AI offers tools that streamline various clinical workflows, particularly in oncology and critical service lines. The platform provides real-time analysis of pathology and radiology reports, ADT feeds, and other clinical data to identify patients earlier, connect them to coordinated care faster, and manage their treatment journeys more efficiently. Key features include real-time cancer patient identification, incidental findings detection, cancer registry automation (Flow™), tumor board management (Compass™), patient care coordination and navigation (Journey™), and real-time data and analytics (Azra IQ™). These capabilities help reduce the time from cancer diagnosis to treatment, improve navigator time with patients, and enhance overall oncology patient retention.
Focus Areas
Business Intelligence
| Key Investors | NewHealth Ventures, SJF Ventures, FCA Venture Partners, Sopris Venture Capital, Connexa Capital |
| Partnerships | HCA Healthcare |
| Acquisitions | Thynk Health (April 2026) |
| Technology | AI-powered enterprise platform, agentic AI, multimodal data integration, workflow automation, cloud-native, real-time processing of pathology and radiology reports, Unified Patient Intelligence Layer |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
For physicians, Azra AI stands out by transforming unstructured clinical data into actionable intelligence, enabling earlier patient identification and faster connection to coordinated care. The platform's high-precision AI (up to 98%) minimizes false positives and reduces the time from diagnosis to treatment (by an average of seven days). It automates manual, repetitive processes, allowing oncology care teams to focus on patient care rather than administrative tasks. The system provides 100% analysis transparency for clinical trial pre-screening, with precise document text citations. Furthermore, Azra AI integrates with existing EHR systems, ensuring that the EHR remains the system of record while Azra acts as an enterprise patient management layer, eliminating double documentation.
Azra AI is designed for seamless integration with existing Electronic Health Record (EHR) systems. They overlay the EHR with bidirectional integration, transforming stored clinical data into structured, accountable workflows embedded within existing systems. The platform also integrates with various data sources, including pathology and radiology reports, ADT feeds, and physician notes. Recent acquisitions, such as Thynk Health, have expanded their integration capabilities to include lung cancer screening and incidental findings management. Partnerships with companies like Riverain Technologies and 4DMedical further enhance their ability to integrate advanced AI for end-to-end lung cancer detection, quantitative lung imaging analytics, and care coordination.
What the Web Says
Azra AI is a health technology company that provides an AI-powered, end-to-end oncology platform designed to optimize clinical workflows in healthcare, particularly in oncology and radiology. Their technology automates the identification and prioritization of cancer patients from pathology reports, manages incidental findings in radiology, and streamlines tumor registry processes. The platform aims to improve patient care, reduce workflow inefficiencies, and ensure compliance with regulatory standards.
Overall: PositiveStrengths
- High precision AI (up to 98%) minimizes false positives in identifying cancer diagnoses and suspicious incidental findings.
- Only end-to-end platform covering the entire continuum of cancer care, from suspicion to survivorship.
- Demonstrated significant ROI for health systems, including a seven-day decrease in time from diagnosis-to-treatment.
- Customizable workflows to fit individual health system needs.
- Full EHR integration eliminates double documentation.
- Increases patient retention and allows clinicians to spend more time with patients.
Limitations
- Limited public reviews and ratings available on major review platforms like G2, Glassdoor, and Capterra.
- Primary focus is on oncology, which may limit its use in other service lines.
- Enterprise pricing is not publicly disclosed.
- Some general Reddit discussions about AI tools mention a lack of documentation and customer support for certain platforms, though not specifically Azra AI.
Based on reviews from: Elion, Azra-AI_HCA Case Study_2023, Becker's Hospital Review, IntuitionLabs, G2, Reddit
Last updated: 2026-09-10
Videos
News, demos, and interviews about Azra AI.
Videos load interactively. If none appear, search YouTube for Azra AI →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]